Bhakti Arondekar
Datos Biográficos
| ID | 5545829 |
|---|---|
| NOMBRE | Bhakti Arondekar |
| NOMBRES | Bhakti |
| APELLIDO | Arondekar |
| FIRMA | ARONDEKAR B |
| AFILIACIONES | GlaxoSmithKline (United States) |
| ORCID | 0000-0002-4553-0094 |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2008 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2008 |
| ÍNDICE H | 0 |
Medical Care Costs One Year After Identification of Hyperglycemia Below the Threshold for Diabetes
OBJECTIVE: To estimate the resource utilization and medical costs of patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or both, in a real-world clinical setting. METHODS: We used fasting and random glucose test results and a previously validated predictive equation to identify glycemic status in 26,111 nondiabetic patients, assigning them to categories of normoglycemia, isolated IFG (I-IFG), isolated IGT (I-IGT), or …
Sin obras prominentes en esta página.
Medical Care Costs One Year After Identification of Hyperglycemia Below the Threshold for Diabetes
OBJECTIVE: To estimate the resource utilization and medical costs of patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or both, in a real-world clinical setting. METHODS: We used fasting and random glucose test results and a previously validated predictive equation to identify glycemic status in 26,111 nondiabetic patients, assigning them to categories of normoglycemia, isolated IFG (I-IFG), isolated IGT (I-IGT), or …
Blood sugar regulation (1 obras) · Diabetes mellitus (1 obras) · Diabetes Treatment and Management (1 obras) · Diabetes, Cardiovascular Risks, and Lipoproteins (1 obras) · Endocrinology (1 obras) · Endocrinology (1 obras) · Glycemic (1 obras) · Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 obras) · Impaired fasting glucose (1 obras) · Impaired glucose tolerance (1 obras)